Transcene Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	360.13	200.22	124.76
Revenue Growth (YoY)	79.86%	60.48%	-
Cost of Revenue	252.31	180.22	102.17
Gross Profit	107.82	20	22.6
Selling, General & Admin	66.62	68.4	49.56
Research & Development	21.25	25.43	66.63
Operating Expenses	87.12	95.73	115.93
Operating Income	20.7	-75.72	-93.34
Interest Expense	-19.45	-15.61	-5.73
Interest & Investment Income	0.81	0.92	0.83
Earnings From Equity Investments	-1.23	-	-
Currency Exchange Gain (Loss)	-1.39	0.69	0.42
Other Non Operating Income (Expenses)	0.28	1.6	2.72
EBT Excluding Unusual Items	-0.29	-88.13	-95.1
Gain (Loss) on Sale of Assets	-3.34	-0.01	-0.37
Pretax Income	-3.63	-88.14	-95.47
Income Tax Expense	-0.07	-9.27	-7.95
Net Income	-3.55	-78.87	-87.52
Net Income to Common	-3.55	-78.87	-87.52
Shares Outstanding (Basic)	38	37	32
Shares Outstanding (Diluted)	38	37	32
Shares Change (YoY)	4.18%	14.53%	-
EPS (Basic)	-0.09	-2.15	-2.74
EPS (Diluted)	-0.09	-2.15	-2.74
Free Cash Flow	86.22	-171.95	-448.43
Free Cash Flow Per Share	2.26	-4.70	-14.03
Gross Margin	29.94%	9.99%	18.11%
Operating Margin	5.75%	-37.82%	-74.81%
Profit Margin	-0.99%	-39.39%	-70.15%
Free Cash Flow Margin	23.94%	-85.88%	-359.42%
EBITDA	93.88	-27.05	-67.14
EBITDA Margin	26.07%	-13.51%	-53.81%
D&A For EBITDA	73.18	48.68	26.2
EBIT	20.7	-75.72	-93.34
EBIT Margin	5.75%	-37.82%	-74.81%

Source: S&P Capital IQ. Standard template. Financial Sources.